114 related articles for article (PubMed ID: 16633575)
1. Mannose-pepstatin conjugates as targeted inhibitors of antigen processing.
Free P; Hurley CA; Kageyama T; Chain BM; Tabor AB
Org Biomol Chem; 2006 May; 4(9):1817-30. PubMed ID: 16633575
[TBL] [Abstract][Full Text] [Related]
2. A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A.
Zaidi N; Burster T; Sommandas V; Herrmann T; Boehm BO; Driessen C; Voelter W; Kalbacher H
Biochem Biophys Res Commun; 2007 Dec; 364(2):243-9. PubMed ID: 17937927
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors.
Raiber EA; Tulone C; Zhang Y; Martinez-Pomares L; Steed E; Sponaas AM; Langhorne J; Noursadeghi M; Chain BM; Tabor AB
ACS Chem Biol; 2010 May; 5(5):461-476. PubMed ID: 20349916
[TBL] [Abstract][Full Text] [Related]
4. The expression and function of cathepsin E in dendritic cells.
Chain BM; Free P; Medd P; Swetman C; Tabor AB; Terrazzini N
J Immunol; 2005 Feb; 174(4):1791-800. PubMed ID: 15699105
[TBL] [Abstract][Full Text] [Related]
5. Macrophage endosomes contain proteases which degrade endocytosed protein ligands.
Diment S; Stahl P
J Biol Chem; 1985 Dec; 260(28):15311-7. PubMed ID: 3905794
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells.
Burster T; Reich M; Zaidi N; Voelter W; Boehm BO; Kalbacher H
Biochem Biophys Res Commun; 2008 Dec; 377(4):1299-303. PubMed ID: 18996084
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical Properties of Bovine Serum Albumin-Glucose and Bovine Serum Albumin-Mannose Conjugates Prepared by Pulsed Electric Fields Treatment.
Jian W; Wang L; Wu L; Sun YM
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510477
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of cathepsin inhibitors on rat embryonic development in vitro. Evidence that cathepsin D is unimportant in the proteolytic function of yolk sac.
Freeman SJ; Brown NA
J Embryol Exp Morphol; 1985 Apr; 86():271-81. PubMed ID: 4031744
[TBL] [Abstract][Full Text] [Related]
9. Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes.
Zou J; Henderson L; Thomas V; Swan P; Turner AN; Phelps RG
J Am Soc Nephrol; 2007 Mar; 18(3):771-9. PubMed ID: 17287425
[TBL] [Abstract][Full Text] [Related]
10. Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.
Kwan JC; Eksioglu EA; Liu C; Paul VJ; Luesch H
J Med Chem; 2009 Sep; 52(18):5732-47. PubMed ID: 19715320
[TBL] [Abstract][Full Text] [Related]
11. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.
Zhang T; Maekawa Y; Yasutomo K; Ishikawa H; Fawzy Nashed B; Dainichi T; Hisaeda H; Sakai T; Kasai M; Mizuochi T; Asao T; Katunuma N; Himeno K
Biochem Biophys Res Commun; 2000 Sep; 276(2):693-701. PubMed ID: 11027533
[TBL] [Abstract][Full Text] [Related]
12. Bridging Small Molecules to Modified Bacterial Microparticles Using a Disulphide Linkage: MIS416 as a Cargo Delivery System.
Mainini F; Larsen DS; Webster GA; Young SL; Eccles MR
PLoS One; 2015; 10(12):e0145403. PubMed ID: 26695183
[TBL] [Abstract][Full Text] [Related]
13. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
Kay J; Afting EG; Aoyagi T; Dunn BM
Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
[TBL] [Abstract][Full Text] [Related]
14. Interaction of human cathepsin D with the inhibitor pepstatin.
Knight CG; Barrett AJ
Biochem J; 1976 Apr; 155(1):117-25. PubMed ID: 938470
[TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based Vector.
Vezenkov LL; Sanchez CA; Bellet V; Martin V; Maynadier M; Bettache N; Lisowski V; Martinez J; Garcia M; Amblard M; Hernandez JF
ChemMedChem; 2016 Feb; 11(3):302-8. PubMed ID: 26639308
[TBL] [Abstract][Full Text] [Related]
16. Dipeptide mimic oligomer transporter mediates intracellular delivery of Cathepsin D inhibitors: a potential target for cancer therapy.
Maynadier M; Vezenkov LL; Amblard M; Martin V; Gandreuil C; Vaillant O; Gary-Bobo M; Basile I; Hernandez JF; Garcia M; Martinez J
J Control Release; 2013 Oct; 171(2):251-7. PubMed ID: 23899821
[TBL] [Abstract][Full Text] [Related]
17. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and initial crystallographic results for pepstatin A inhibited bovine cathepsin D.
Bieber F; Brachvogel V; Arni R; Fusek M; Metcalf P
J Mol Biol; 1992 Oct; 227(4):1265-8. PubMed ID: 1433300
[TBL] [Abstract][Full Text] [Related]
19. No role for pepstatin-A-sensitive acidic proteinases in reovirus infections of L or MDCK cells.
Kothandaraman S; Hebert MC; Raines RT; Nibert ML
Virology; 1998 Nov; 251(2):264-72. PubMed ID: 9837790
[TBL] [Abstract][Full Text] [Related]
20. New renin inhibitors homologous with pepstatin.
Eid M; Evin G; Castro B; Menard J; Corvol P
Biochem J; 1981 Aug; 197(2):465-71. PubMed ID: 7034718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
